Characteristics of the heterologously ex
✍
Lamb, David C.; Kelly, Diane E.; Waterman, Michael R.; Stromstedt, Maria; Rozman
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 192 KB
Human and Candida albicans CYP51 were purified to homogeneity after GAL10-based heterologous expression in yeast in order to resolve the basis for the selective inhibition of the fungal enzyme over the human orthologue by the azole drugs ketoconazole and itraconazole, used in the treatment of system